FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be sued in treatment of macular hole of retina after performed operation. For this purpose 60% solution of lornoxicam is used. Medication is instilled into conjunctival cavity of operated eye in dose 1 drop 4 times per day, during three weeks.
EFFECT: method ensures closing of macular hole in short term due to elaborated doses and mode of introduction of medication, first proposed in form of eye drops and ensuring in such application efficient suppression of inflammation processes in tissue of retina and stability of obtained result.
8 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIATED APPROACH OF USING ENRICHED THROMBOCYTIC PLASMA IN OPERATIVE THERAPY OF COMPLICATED OPTIC DISC PIT | 2018 |
|
RU2686419C1 |
| METHOD OF TREATING OCCLUSION OF CENTRAL VEIN OF RETINA AND ITS BRANCHES | 2015 |
|
RU2603318C1 |
| ANTI-INFLAMMATORY AND MYDRIATIC INTRA-CHAMBER SOLUTIONS FOR INHIBITION OF POSTOPERATIVE INFLAMMATORY EYE CONDITIONS | 2015 |
|
RU2750296C2 |
| METHOD OF TREATING MACULAR RUPTURE COMPLICATED BY DRUSENOID DETACHMENT OF RETINAL PIGMENT EPITHELIUM | 2022 |
|
RU2820489C1 |
| METHOD FOR SURGICAL MANAGEMENT OF MACULAR OEDEMA FOLLOWING CATARACT PHACOEMULSIFICATION | 2010 |
|
RU2453297C2 |
| METHOD FOR REMOVING THE INTERNAL LIMITING MEMBRANE OF THE RETINA | 2023 |
|
RU2804717C1 |
| METHOD OF COMBINED TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY CENTRAL RETINAL RUPTURE WITH ACCOMPANYING RETINOSCHISIS AND TRACTION-RHEGMATOGENOUS RETINAL DETACHMENT | 2023 |
|
RU2816782C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF NEOVASCULAR FORM OF AMD | 2022 |
|
RU2788103C1 |
| RECURRENT MACULAR RUPTURE SURGERY TECHNIQUE | 2016 |
|
RU2633338C2 |
| METHOD FOR FORMING FOVEOLAR FRAGMENT OF INTERNAL LIMITING MEMBRANE IN SURGICAL MANAGEMENT OF MACULAR OEDEOMA OF VARIOUS ETHIOLOGY | 2014 |
|
RU2563438C1 |
